Intuitive Surgical has delivered a 44.7% share price gain over the past three years, even as the stock has fallen over the past year, which puts the focus squarely on whether that performance lines up with the cash the business is expected to generate. With a Discounted Cash Flow (DCF) view available on the stock, the question for investors is how well today's market value lines up with those projected cash streams.
For investors, the debate is whether Intuitive Surgical's current share price is properly supported by the cash flows implied by its intrinsic value estimate from the Discounted Cash Flow (DCF) approach.
If you want to test this same cash flow question across a wider set of surgical robotics and automation players, scan through 85 robotics and automation stocks.
The Discounted Cash Flow (DCF) approach here focuses on how much cash Intuitive Surgical can return to shareholders over time. Latest twelve month free cash flow sits at about $3.1b, and the model assumes that figure keeps growing rather than shrinking, with projected annual free cash flows moving into the mid single digit billions over the coming decade.
Those rising cash streams, when discounted back, put the estimated intrinsic value broadly in line with the current share price of $439.89. The recent 22% year on year revenue increase and higher procedure volumes help explain why the market is willing to pay up for that growth profile, even as fresh competition and pricing pressure weigh on sentiment. Find out what Intuitive Surgical could be worth using our Discounted Cash Flow (DCF) estimate.
Simply Wall St Narratives for Intuitive Surgical pick up where the DCF question leaves off. Narratives describe which paths for Intuitive Surgical's growth, margins and earnings would need to occur for the shares to appear meaningfully higher or lower than today. Each narrative links a fair value estimate to a specific mix of potential catalysts and risks so you can track over time which version of events is actually unfolding on the Community page.
Bulls in Intuitive Surgical focus on the depth of the ecosystem, while bears focus on how much pressure that ecosystem might face.
Bull case: 17% undervalued
Tokyo, a Simply Wall St Community investor who wrote the Narrative, frames the upside in Intuitive Surgical around the da Vinci platform and its data loop.
"By integrating data analytics, AI-powered insights, and global knowledge-sharing, Intuitive has not only revolutionized robotic surgery but also created an ecosystem that continuously enhances surgical skills and patient outcomes..."
Discover why this Narrative puts Intuitive Surgical at 17% undervalued.
Bear case: 28% overvalued
The bearish analyst Narrative on Simply Wall St argues that Intuitive Surgical faces rising competition and policy pressure on its installed base returns.
"Bearish analysts expect Intuitive Surgical to experience sustained margin pressure as pricing competition, policy headwinds and new robotic entrants compress returns on its growing installed base..."
Explore why this Narrative puts Intuitive Surgical at 28% overvalued.
Before you stop at cash flows and scenarios for Intuitive Surgical, it is worth asking who is steering the business and what kind of incentives shape their choices. See who runs Intuitive Surgical and how they are paid.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com